Advertisement
Product › Details
Affilin® therapeutic
Next higher product group | therapeutic protein | |
Organisation | Scil Proteins GmbH | |
Today | Navigo Proteins GmbH | |
Group | UV-Cap (Vetter family office) (Group) | |
Record changed: 2023-07-10 |
Advertisement
More documents for therapeutic protein
- [1] Navigo Proteins GmbH. (9/6/23). "Press Release: Navigo Proteins and Nostrum Biodiscovery Announce a Research Collaboration to Enhance Affilin Ligand Discovery Using Cutting-edge AI and Molecular Modeling Techniques". Halle (Saale) & Barcelona....
- [2] Mallia Therapeutics GmbH. (7/11/23). "Press Release: Mallia Therapeutics Secures Seed Funding for its Novel Topical Treatment to Induce Hair Growth via Immune Modulation". Erlangen....
- [3] ProteoNic B.V.. (10/20/20). "Press Release: ProteoNic Announces Licensing of Technology for Production of Biologics to Immunomedics". Leiden....
- [4] Merck KGaA. (7/6/20). "Press Release: Merck Announces VAR2 Pharmaceuticals as Winner of its Advance Biotech Grant". Darmstadt....
- [5] Albumedix Ltd.. (6/1/20). "Press Release: Albumedix Announces Appointment of Gregor Kawaletz as Chief Commercial Officer"....
- [6] Albumedix Ltd.. (5/26/20). "Press Release: Albumedix Announces Jonas Skjødt Møller as New Chief Executive Officer"....
- [7] Morphogen-IX Ltd.. (12/20/18). "Press Release: Morphogen-IX Raises £18.4M ($23.2M) in a Series B Financing". Cambridge....
- [8] Morphogen-IX Ltd.. (6/28/18). "Press Release: Morphogen-IX Appoints CEO and Forms Global Scientific Advisory Board". Cambridge....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top